| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 40 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 40 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 40 |
| 3 | PREDNISONE | 40 |
| 4 | RITUXIMAB | 39 |
| 5 | DOXORUBICIN | 33 |
| 6 | RANITIDINE | 31 |
| 7 | DEXAMETHASONE | 28 |
| 8 | DEXAMETHASONE 1.5 MG | 28 |
| 9 | ADALIMUMAB | 27 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLORPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HCL | 1 | 0.0040 |
| 1 | SODIUM IODIDE I 123 | 3 | 0.0032 |
| 2 | CARMUSTINE | 15 | 0.0032 |
| 3 | SODIUM IODIDE I 131 | 3 | 0.0031 |
| 4 | MILNACIPRAN HYDROCHLORIDE | 14 | 0.0023 |
| 5 | AXICABTAGENE CILOLEUCEL | 14 | 0.0014 |
| 6 | LISOCABTAGENE MARALEUCEL | 1 | 0.0011 |
| 7 | SACCHAROMYCES CEREVISIAE | 1 | 0.0011 |
| 8 | ILOPROST | 1 | 0.0011 |
| 9 | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 71 |
| 1 | Alkylating Drug [EPC] | 46 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 39 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 38 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 37 |
| 5 | Platinum-based Drug [EPC] | 33 |
| 6 | Topoisomerase Inhibitor [EPC] | 28 |
| 7 | Benzodiazepine [EPC] | 26 |
| 8 | Kinase Inhibitor [EPC] | 23 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 4 | 0.0022 |
| 1 | CD19-directed Chimeric Antigen Receptor [EPC] | 14 | 0.0014 |
| 2 | Prostacycline [EPC] | 1 | 0.0011 |
| 3 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 4 | Estrogen Agonist/Antagonist [EPC] | 1 | 0.0004 |
| 5 | Topoisomerase Inhibitor [EPC] | 28 | 0.0004 |
| 6 | Autologous Cellular Immunotherapy [EPC] | 2 | 0.0003 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 3 | 0.0003 |
| 8 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 9 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |